目次

Table of Content

1. Introduction To Transdermal Patch
1.1 Overview Of Transdermal Patch
1.2 Relevance Of Transdermal Patch

2. Transdermal Patches Classification
2.1 Single/ Multiple Layer Drug In Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch

3. Mechanism Of Transdermal Patch Drug Delivery
3.1 Properties Of Transdermal Therapeutics
3.2 Components Of Transdermal Patch
3.3 Mechanism Of Motion Sickness, Nicotine and Female Contraceptive Transdermal
Patch
3.4 Transdermal Patch v/s Traditional Drug Delivery Methods

4. Global Transdermal Patch Market Outlook
4.1 Current Market Scenario
4.2 Future Market Opportunity

5. Global Transdermal Patch Market Trends By Region
5.1 US
5.2 Europe
5.3 China
5.4 Japan
5.5 South Korea
5.6 UK

6. Global Patch Clinical Pipeline By Company, Indication and Phase
6.1 Research
6.2 Preclinical
6.3 Phase-I
6.4 Phase-I/II
6.5 Phase-II
6.6 Phase-III
6.7 Preregistration
6.8 Registered

7. Global Marketed Transdermal Patch Clinical Insight

8. Transdermal Patches For Cardiovascular Diseases - Market Availability, Dosage and Price Analysis
8.1 Nitroglycerin Transdermal Patch
8.1.1 Nitro-Dur
8.1.2 Nitro TD Patch A
8.1.3 Generic Nitroglycerin Transdermal Patch
8.2 Clonidine Transdermal Patch
8.2.1 Catapres-TTS
8.2.2 Generic Clonidine Transdermal Patch
8.3 Bisoprolol Transdermal Patch (Bisono)

9. Transdermal Analgesic Patches - Market Availability, Dosage and Price Analysis
9.1 Fentanyl Transdermal Patch
9.1.1 Duragesic/Durogesic
9.1.2 Durotep MT
9.1.3 OneDuro
9.1.4 Generic Fentanyl Transdermal Patch
9.1.5 Fentos
9.1.6 Fentadur
9.1.7 Generic Fentanyl Citrate Transdermal Patch
9.2 Buprenorphine Transdermal Patch
9.2.1 Butrans
9.2.2 Bunov
9.2.3 Sevodyne
9.2.4 Transtec
9.2.5 Generic Buprenorphine Transdermal Patch
9.3 Diclofenac Transdermal Patch
9.3.1 Zicthoru
9.3.2 Flector
9.3.3 Licart
9.4 Ketoprofen Transdermal Patch (Mohrus)
9.5 Lidocaine Transdermal Patch
9.5.1 Versatis
9.5.2 ZTlido
9.5.3 Penles
9.5.4 Rapydan
9.6 Capsaicin Transdermal Patch (Qutenza)
9.7 Methyl Salicate Transdermal Patch
9.7.1 Salonpas
9.7.2 Tokuhon
9.8 Glycol Salicylate Transdermal Patch (Tokuhon E)
9.9 Flurbiprofen Transdermal Patch
9.9.1 Loqoa
9.9.2 Yakuban Tape
9.9.3 Transact Lat

10. Transdermal Patch In Hormonal Therapy - Market Availability, Dosage and Price Analysis
10.1 Estradiol Transdermal Patch
10.1.1 Alora
10.1.2 Vivelle-Dot
10.1.3 Minivelle
10.1.4 Climara
10.1.5 Menostar
10.1.6 FemSeven
10.1.7 Estrana
10.1.8 Generic Estradiol Transdermal Patch
10.2 Testosterone Transdermal Patch (Androderm)
10.3 Estradiol/ Norethisterone Transdermal Patch
10.3.1 Xulane/Ortho Evra
10.3.2 Combipatch
10.3.3 Menoaid Combi Patch
10.3.4 Evorel Conti
10.4 Estradiol/Levonorgestrel Transdermal Patch
10.5 Ethinyl Estradiol/Levonorgestrel (Twirla)
10.6 Ethinyl Estradiol/Gestodene (Apleek)

11. Transdermal Patches For Neurological Disorders - Market Availability, Dosage and Price Analysis
11.1 Scopolamine Transdermal Patch (Transderm-Scop)
11.2 Selegiline Transdermal Patch (Emsam)
11.3 Methylphenidate Transdermal Patch (Daytrana)
11.4 Dextroamphetamine Transdermal Patch (Xelstrym)
11.5 Blonanserin Transdermal Patch (Lonasen)
11.6 Asenapine Transdermal Patch (Secuado)
11.7 Rivastigmine Transdermal Patch
11.7.1 Exelon
11.7.2 Generic Rivastigmine Transdermal Patch
11.8 Rotigotine Transdermal Patch (Neupro)
11.9 Ropinirole Hydrochloride (Haruropi Tape)
11.10 Donepezil Transdermal Patch (Adlarity)

12. Patches For Other Conditions - Market Availability, Dosage and Price Analysis
12.1 Nicotine Transdermal Patch (Nicoderm CQ/ Nicotinell TTS)
12.2 Oxybutynin Transdermal Patch (Oxytrol/Kentera)
12.3 Granisetron Transdermal Patch (Sancuso)
12.4 Emedastine Transdermal Patch (Allesaga)
12.5 Fibrin Sealant Transdermal Patch
12.5.1 Evarrest
12.5.2 TachoSil
12.6 5-Aminolevulinic Acid Transdermal Patch (Alacare)
12.7 Tulobuterol Transdermal Patch
12.7.1 Tulo-Touch
12.7.2 Hokunarin

13. Global Transdermal Patch Market Dynamics
13.1 Favorable Market Parameters
13.2 Commercialization Challenges

14. Competitive Landscape
14.1 AbbVie
14.2 Bayer HealthCare Pharmaceuticals
14.3 Corium International
14.4 Endo Pharmaceuticals
14.5 Hisamitsu Pharmaceutical
14.6 Luye Pharma
14.7 Noven Pharmaceuticals
14.8 Novartis
14.9 Purdue Pharma
14.10 Scilex Pharmaceuticals
14.11 Searchlight Pharma
14.12 Somerset Pharmaceuticals
14.13 Teikoku Seiyaku
14.14 Teva Pharmaceuticals
14.15 UCB
14.16 DURECT Corporation
14.17 Senju Pharmaceutical

List of Figures
Figure 1-1: Transdermal Permeation - Steps Involved
Figure 1-2: Transdermal Patch - Ideal Properties
Figure 2-1: Commercially Available Transdermal Patch Types
Figure 2-2: Multilayer Transdermal Patch
Figure 2-3: Reservoir Transdermal Patch System
Figure 2-4: Matrix Based Transdermal Patches
Figure 3-1: Transdermal Therapeutics - Properties
Figure 3-2: Transdermal Patch - Components
Figure 3-3: Permeation Enhancer - Types
Figure 3-4: Iontophoresis - Schematic Representation
Figure 3-5: Scopolamine Transdermal Patch - Mechanism
Figure 3-6: Nicotine Transdermal Patch - Mechanism
Figure 3-7: Female Contraceptive Transdermal Patch - Mechanism
Figure 3-8: Traditional Drug Delivery Methods - Challenges
Figure 3-9: Transdermal Patch - Advantages
Figure 3-10: Consistent Drug Supply By Transdermal Patch
Figure 4-1: Global - Transdermal Patch Market Size (US$ Billion), 2024 - 2030
Figure 4-2: Global Transdermal Patch Market By Region (US$ Billion), 2024
Figure 4-3: Global Transdermal Patch Market By Region (%), 2024
Figure 4-4: Global Transdermal Patch Market By Region (US$ Billion), 2030
Figure 4-5: Global Transdermal Patch Market By Region (%), 2030
Figure 8-1: Nitro-Dur - Price Per Unit and Supply Of Transdermal Films (US$), March’2025
Figure 8-2: Nitro TD Patch A - Price Per Unit and Supply Of Transdermal Films (US$), February’2025
Figure 8-3: Generic Nitroglycerin Transdermal Patch - Price Per Unit and Supply (US$), February’2025
Figure 8-4: Catapres-TTS - FDA Approval and First Generic Approval Year
Figure 8-5: Catapres-TTS - Price Per Unit and Supply (US$), February’2025
Figure 8-6: Catapres-TTS Transdermal Patch - Recommended Initial and Incremented Dose (mg/Week)
Figure 8-7: Generic Clonidine Transdermal Patch - Price Per Unit and Supply (US$), February’2025
Figure 8-8: Bisono - Approval Year By Indication
Figure 8-9: Bisono - Price Per Unit By Dose (US$), February’2025
Figure 8-10: Bisono - Initial and Maximum Recommended Dose (mg/hr)
Figure 9-1: Duragesic - Approval Year By Region
Figure 9-2: Durotep MT - Price Per Unit By Dose (US$), February’2025
Figure 9-3: OneDuro - Price Per Unit By Dose (US$), February’2025
Figure 9-4: Generic Fentanyl Transdermal Patch - Price Per Unit and Supply In US (US$), March’2025
Figure 9-5: Fentos - Price Per Unit By Dose (US$), February’2025
Figure 9-6: Fentos - Annual Sales (US$), 2020-2024
Figure 9-7: Generic Fentanyl Citrate Transdermal Patch - Price Per Unit By Dose (US$), February’2025
Figure 9-8: Butrans - FDA Approval Year By Dose
Figure 9-9: US - Butrans FDA Approval and 1st Generic Approval Year
Figure 9-10: Butrans - Approval Year By Region
Figure 9-11: Butrans - Price Per Unit and Supply In US (US$), March’2025
Figure 9-12: Butrans - Initial and Maximum Recommended Dose (mcg/hr)
Figure 9-13: Butrans - Price Per Unit and Supply In UK (US$), February’2025
Figure 9-14: Bunov - Initial and Maximum Recommended Dose (mg/hr)
Figure 9-15: Sevodyne - Price Per Supply (US$), February’2025
Figure 9-16: Transtec - Price Per Supply In UK (US$), February’2025
Figure 9-17: Generic Buprenorphine Transdermal Patch - Price Per Unit and Supply In US (USS), March’2025
Figure 9-18: Zicthoru - Price Per Unit and Supply (US$), February’2025
Figure 9-19: Zicthoru - Annual Sales (US$), 2021-2024
Figure 9-20: Branded and Generic Flector Patch - Price Per Unit and Supply In US (US$), March’2025
Figure 9-21: Licart - Price Per Unit and Supply In US (US$), March’2025
Figure 9-22: Mohrus - Price Per Supply By Dose (US$), February’2025
Figure 9-23: Mohrus - Annual Sales (US$), 2020-2024
Figure 9-24: Versatis - Price Per Supply By Region (US$), February’2025
Figure 9-25: ZTlido - Price Per Unit and Supply (US$), February’2025
Figure 9-26: Qutenza - Price Per Unit By Region (US$), February’2025
Figure 9-27: Salonpas - Price Per Unit and Supply In US (US$), March’2025
Figure 9-28: Generic Methyl Salicylate Patch - Price Per Unit and Supply In US (US$), March’2025
Figure 9-29: Tokuhon - Price Per Supply (US$), February’2025
Figure 9-30: Yakuban Tape - Price Per Supply Of 60mg Tape (US$), February’2025
Figure 9-31: Yakuban Tape - Price Per Supply Of 20mg Tape (US$), February’2025
Figure 9-32: TransAct Lat - Price Per Supply By Online Pharmacy (US$), February’2025
Figure 10-1: Alora - FDA Approval Year By Dose
Figure 10-2: Alora - Recommended Dose For Treatment Of Vaginal Atrophy and Postmenopausal Osteoporosis (mg/Day Twice In A Week)
Figure 10-3: Vivelle-Dot - FDA Approval and First Generic Approval Year
Figure 10-4: Vivelle-Dot - Price Per Unit and Supply In US (US$), March’2025
Figure 10-5: Vivelle-Dot - Recommended Dose (mg/Day Twice a Week)
Figure 10-6: Vivelle-Dot - Annual Sales (US$), 2020-2024
Figure 10-7: Minivelle - FDA Approval Year By Dose
Figure 10-8: Minivelle - FDA Approval and First Generic Approval Year
Figure 10-9: US - Minivelle Patent Issue and Expiration Year
Figure 10-10: Minnivelle - Price Per Unit and Supply In US (US$), March’2025
Figure 10-11: Minivelle - Recommended Dose By Indication (mg/Day)
Figure 10-12: Minivelle - Annual Sales (US$), 2020-2024
Figure 10-13: Climara - FDA Approval Year By Dose
Figure 10-14: Climara - FDA Approval and First Generic Approval Year
Figure 10-15: Climara - Price Per Unit and Supply In Canada (US$), February’2025
Figure 10-16: Menostar - Price Per Unit and Supply In US (US$), March’2025
Figure 10-17: FemSeven - Price Per Unit and Supply (Euro/US$), February’2025
Figure 10-18: FemSeven - Initial and Increased Dosage For Postmenopausal Symptoms (mg/hr)
Figure 10-19: Estrana - Price Per Supply (US$), February’2025
Figure 10-20: Estrana - Annual Sales (US$), 2020-2024
Figure 10-21: Generic Estradiol Transdermal Patch - Price Per Unit and Supply Of Twice Weekly Patch In US (US$), March’2025
Figure 10-22: Generic Estradiol Transdermal Patch - Price Per Unit and Supply Of Weekly Patch In US (US$), March’2025
Figure 10-23: Androderm - Price Per Unit and Supply In US (US$), March’2025
Figure 10-24: Androderm - Recommended Initial and Maintainence Dose For Treatment of Hypogonadism (mg/day)
Figure 10-25: Xulane - FDA Approval and First Generic Approval Year
Figure 10-26: Ortho Evara - FDA and EMA Approval Year
Figure 10-27: Xulane and Zafemy - Price Per Unit and Supply In US (US$), March’2025
Figure 10-28: Ethinyl Estradiol/Norelgestromin Patch - Recommended Schedule for Achieving Birth Control Effect (Days)
Figure 10-29: Evra - Price Per Unit and Supply In UK (US$), February’2025
Figure 10-30: CombiPatch - Price Per Unit and Supply In US (US$), March’2025
Figure 10-31: CombiPatch - Price Per Unit and Supply In Canada (US$), February’2025
Figure 10-32: CombiPatch - Annual Sales (US$), 2020-2024
Figure 10-33: Estradiol/Levonorgestrel - Approval Year By Region
Figure 10-34: Climara Pro - Price Per Unit and Supply In US (US$), March’2025
Figure 10-35: FemSeven Conti - Price Per Unit and Supply In UK (US$), February’2025
Figure 10-36: US - Twirla Patent Issue and Expiration Year
Figure 10-37: Twirla - Price Per Unit and Supply (US$), March’2025
Figure 10-38: Twirla - Recommended Schedule For Achieving Birth Control Effect (Days)
Figure 11-1: Transderm-Scop - FDA Approval and 1st Generic Approval Year
Figure 11-2: Transderm-Scop - Price Per Unit and Supply (US$), March’2025
Figure 11-3: Scopolamine - Price Per Unit and Supply (US$), March’2025
Figure 11-4: Emsam - Price Per Unit and Supply (US$), March’2025
Figure 11-5: Daytrana - FDA Approval and Patent Exclusivity Year
Figure 11-6: US - Daytrana Patent Issue and Expiration Year
Figure 11-7: Daytrana - Price Per Unit and Supply (US$), March’2025
Figure 11-8: Daytrana - Annual Sales (US$), 2020-2024
Figure 11-9: Xelstrym - Price Per Unit and Supply (US$), March’2025
Figure 11-10: Xelstrym - Annual Sales (US$), 2023-2024
Figure 11-11: Lonasen - Price Per Unit in Japan (US$), February’2025
Figure 11-12: US - Secuado Patent Issue and Expiration Year
Figure 11-13: Secuado - Price Per Unit and Supply (US$), March’2025
Figure 11-14: Secuado - Recommended Initial and Incremented Dose (mg/Day)
Figure 11-15: Secuado - Annual Sales (US$), 2020-2024
Figure 11-16: Exelon - Approval Year By Region
Figure 11-17: US - Exelon FDA Approval Year and 1st Generic Approval Year
Figure 11-18: Exelon - Price Per Unit and Supply In US (US$), March’2025
Figure 11-19: Generic Rivastigmine Patch - Price Per Unit and Supply (US$), March’2025
Figure 11-20: Neupro - Approval Year By Region
Figure 11-21: US - Neupro Approval Year By Indication
Figure 11-22: Neupro - Patent Issue and Expiration Year
Figure 11-23: Neupro - Price Per Unit and Supply (US$), March’2025
Figure 11-24: Neupro - Initial and Maximum Recommended Dose for Early Stage Parkinson (mg/day)
Figure 11-25: Neupro - Initial and Maximum Recommended Dose for Late Stage Parkinson (mg/day)
Figure 11-26: Neupro - Initial and Maximum Recommended Dose for Restless Leg Syndrome (mg/day)
Figure 11-27: Global - Neupro Sales (US$ Million), 2020-2024
Figure 11-28: Haruropi Tape Patch - Price Per Unit In Japan (US$), February’2025
Figure 11-29: Haruropi Tape - Initial and Maximum Recommended Dose (mg/day)
Figure 11-30: Haruropi - Annual Sales (US$), 2020-2024
Figure 11-31: Adlarity - Price Per Unit and Supply In US (US$), February’2025
Figure 12-1: Nicotine Transdermal Patch - Approval Year By Region
Figure 12-2: Nicoderm CQ - Price Per Unit and Supply (US$), March’2025
Figure 12-3: Generic Nicotine Patch - Price Per Unit and Supply Of 7mg/24hr Transdermal Patches (US$), March’2025
Figure 12-4: Generic Nicotine Patch - Price Per Unit and Supply Of 14mg/24hr Transdermal Patches (US$), March’2025
Figure 12-5: Generic Nicotine Patch - Price Per Unit and Supply Of 21mg/24hr Transdermal Patches (US$), March’2025
Figure 12-6: Nicoderm CQ - Recommended Dose and Treatment Schedule For Patients with Consumption More Than 10 Cigarette/Days (mg/day)
Figure 12-7: Oxybutynin Transdermal Patch - Approval Year By Region
Figure 12-8: Oxytrol - Price Per Unit and Supply In US (US$), March’2025
Figure 12-9: Kentera - Price Per Unit and Supply In UK (US$), February’2025
Figure 12-10: Sancuso - Approval Year By Region
Figure 12-11: US - Sancuso Patent Issue and Expiration Year
Figure 12-12: Allesaga - Price Per Unit By Dose (US$), February’2025
Figure 12-13: Allesaga - Initial and Maximum Recommended Dose (mg/hr)
Figure 12-14: Allesaga - Annual Sales (US$), 2020-2023
Figure 12-15: Tulo-Touch - Price Per Unit By Dose (US$), February’2025
Figure 12-16: Hokunalin - Price Per Unit By Dose (US$), February’2025
Figure 13-1: Global Transdermal Patch Market - Favorable Parameters
Figure 13-2: Global Transdermal Patch Market - Commercialization Challenges

List of Tables
Table 2-1: Active v/s Passive Transdermal Patch
Table 3-1: Transdermal Patches For Various Disease Indications
Table 9-1: Duragesic - Initial Dose Conversion From Other Opioids
Table 9-2: Butrans - Initial Dose Calculation Using Previous Opioid (Morphine) Dosage
Table 11-1: Daytrana - Dose Increment Pattern For Treatment Of ADHD